Lecture Eight
Lecture Eight
Lecture Eight
CLINICAL STAGE 1
Asymptomatic
Persistent generalized swelling of of lymph nodes
CLINICAL STAGE 2
Unexplained moderate weight loss (under 10% of presumed or
Measured body weight)
Recurrent upper respiratory tract infections (sinusitis, tonsillitis, otitis
media, pharyngitis)
Recurrent ulceration
Dermatitis (skin diseases)
Fungal infection e.t.c
CLINICAL STAGE 3
Unexplained severe weight loss (over 10% of presumed or measured
body weight)
Unexplained chronic diarrhoea for longer than one month
Unexplained persistent fever (intermittent or constant for longer than
one month)
Persistent oral candidiasis e.t.c
CLINICAL STAGE 4
HIV wasting syndrome
Pneumonia
Cancer
Central nervous system disorders
HIV encephalopathy
Meningitis
Types/Classes of ARVs
PrEP:
PrEP is a daily pill for HIV-negative people that can help prevent HIV
infection before exposure to the virus. PrEP must be taken for at least 7 days to reach
optimal levels of protection against HIV. PrEP is taken as long as someone is at risk
of HIV infection
SUMMARY
In this lecture we have discussed the WHO clinical staging of HIV disease in
adults and adolescents. We have also looked into the classification of ARVs and
Explained eligibility for PreP and PEP in prevention of HIV infection.
Further reading
Refer to the ART Guidelines (2016) Section 6.1: Eligibility for ART
Refer to the ART Guidelines (2016) Section 10: ARVs for PEP
Activity
Visit the Kenya National Aids & STI Control Program (NASCOP), World
Health Organization (WHO) and USAID websites and write short notes
maximum one page on existing guidelines before initiation of Anti-retroviral
therapy.